US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Candel Therapeutics, Inc.

6.04

+0.49008.83%

Post-market: 5.96-0.0787-1.30%19:47 EDT

Volume:1.14M

Turnover:6.85M

Market Cap:302.62M

PE:-5.60

High:6.20

Open:5.56

Low:5.56

Close:5.55

Loading ...

Overview Company News Filings

Candel Therapeutics Inc. Strengthens Board with Appointment of Maha Radhakrishnan, M.D., Ahead of Key Biologics License Application Submission

Buy Recommendation for Candel Therapeutics: Promising Data on CAN-2409 Treatment for Prostate Cancer

Candel Therapeutics to hold a conference call

Candel Therapeutics Inc. Releases Presentation Highlighting Advances in Cancer Immunotherapy and Promising Clinical Trial Results

Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 in Prostate Cancer Treatment

Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for Can-2409 for the Treatment of Prostate Cancer

THOMSON REUTERS

Candel Therapeutics Unveils Promising Phase 3 Trial Results

Candel Therapeutics Presents Positive Phase 3 Can-2409 Results in Localized Prostate Cancer at Asco 2025

THOMSON REUTERS

Candel Therapeutics Inc - Common Can-2409 Adverse Events Include Flu-Like Symptoms, Fever, and Chills

THOMSON REUTERS

Candel Therapeutics Inc - Phase 3 Trial Shows 30% Reduction in Prostate Cancer Recurrence Risk

THOMSON REUTERS

Candel Therapeutics Inc - Can-2409 Well Tolerated With Low Incidence of Serious Adverse Events

THOMSON REUTERS

BRIEF-Candel Therapeutics Q1 Net Income USD 7.379 Million

Candel Therapeutics Reports Q1 2025 Financials, Highlights Prolonged Survival in Key Trials; No Significant Sales/Revenue Variation Reported

Candel Therapeutics Inc: Submission of Bla for Can-2409 in Prostate Cancer Expected in Q4 2026

THOMSON REUTERS

Candel Therapeutics Q1 Operating Expenses USD 8.13 Million

THOMSON REUTERS

Press Release: Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Calendar of U.S. Earnings Expected in the Week Ahead

Candel Therapeutics’ CAN-2409 Trial Results Accepted at ASCO

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 Can-2409 Results in Localized Prostate Cancer at Asco 2025

THOMSON REUTERS

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CADL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CADL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CADL\",,,,,undefined,":{"symbol":"CADL","market":"US","secType":"STK","nameCN":"Candel Therapeutics, Inc.","latestPrice":6.04,"timestamp":1749240000000,"preClose":5.55,"halted":0,"volume":1144758,"hourTrading":{"tag":"盘后","latestPrice":5.9613,"preClose":6.04,"latestTime":"19:47 EDT","volume":17262,"amount":104335.1847,"timestamp":1749253645346},"delay":0,"floatShares":41997658,"shares":50102679,"eps":-1.078004,"marketStatus":"Market Closed","change":0.49,"latestTime":"06-06 16:00:00 EDT","open":5.56,"high":6.1961,"low":5.56,"amount":6850937.958734401,"amplitude":0.114613,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.078004,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1627358400000,"exchange":"NASDAQ","adjPreClose":5.55,"preHourTrading":{"tag":"盘前","latestPrice":5.65,"preClose":5.55,"latestTime":"09:14 EDT","volume":4520,"amount":25285.497884,"timestamp":1749215644628},"postHourTrading":{"tag":"盘后","latestPrice":5.9613,"preClose":6.04,"latestTime":"19:47 EDT","volume":17262,"amount":104335.1847,"timestamp":1749253645346},"volumeRatio":1.2213761471608284,"impliedVol":0.8488,"impliedVolPercentile":0.348},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CADL\",,,,,undefined,":{"symbol":"CADL","floatShares":41997658,"roa":"-32.31%","roe":"-98.14%","lyrEps":-1.741968,"volumeRatio":1.2213761471608284,"shares":50102679,"dividePrice":0,"high":6.1961,"amplitude":0.114613,"preClose":5.55,"low":5.56,"week52Low":3.785,"pbRate":"4.05","psRate":"9761.94","week52High":14.6,"institutionHeld":0,"latestPrice":6.04,"eps":-1.078004,"divideRate":0,"volume":1144758,"delay":0,"ttmEps":-1.078004,"open":5.56,"prevYearClose":8.68,"prevWeekClose":5.45,"prevMonthClose":5.45,"prevQuarterClose":5.65,"fiveDayClose":5.45,"twentyDayClose":4.76,"sixtyDayClose":8.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CADL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541852274","title":"Candel Therapeutics Inc. Strengthens Board with Appointment of Maha Radhakrishnan, M.D., Ahead of Key Biologics License Application Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2541852274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541852274?lang=en_us&edition=fundamental","pubTime":"2025-06-06 20:05","pubTimestamp":1749211528,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc. Strengthens Board with Appointment of Maha Radhakrishnan, M.D., Ahead of Key Biologics License Application Submission. Candel Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Maha Radhakrishnan, M.D., to its Board of Directors, effective June 4, 2025. This strategic addition comes as Candel progresses towards its Biologics License Application submission for CAN-2409 in intermediate-to-high-risk prostate cancer, expected in Q4 2026. Dr. Radhakrishnan's extensive industry experience is anticipated to support Candel's efforts in advancing its oncology programs towards potential approval and commercial development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL95jZCQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210149790.SGD","LU2095319765.USD","NDAQ","BK4585","BK4139","CADL","BK4539","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BGHQF748.EUR","BK4588","BK4112"],"gpt_icon":0},{"id":"2540305559","title":"Buy Recommendation for Candel Therapeutics: Promising Data on CAN-2409 Treatment for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540305559","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540305559?lang=en_us&edition=fundamental","pubTime":"2025-06-04 17:15","pubTimestamp":1749028552,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Candel Therapeutics (CADL – Research Report) yesterday and set a price...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-candel-therapeutics-promising-data-on-can-2409-treatment-for-prostate-cancer-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-candel-therapeutics-promising-data-on-can-2409-treatment-for-prostate-cancer-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4553","BK4526","LENZ","LU0306806265.USD","LU1201861165.SGD","LU1506573853.SGD","LU2129689431.USD","BK4007","BK4504","IE0002270589.USD","IE00BBT3K403.USD","BK4534","LU0683600562.USD","CADL","LU0787776722.HKD","LU0417517546.SGD","LU0314106906.USD","LU0648001328.SGD","LU0130103400.USD","LU1280957306.USD","LU0234572021.USD","LU1162221912.USD","LU2129689605.HKD","IE00B19Z3581.USD","BK4559","LU0320765646.SGD","LU0052756011.USD","LU1718418525.SGD","LU0256863811.USD","BK4207","LU1496350502.SGD","IE00B19Z3B42.SGD","LU1363072403.SGD","BK4585","LU0971096721.USD","LU1880398471.USD","BK4170","LU1366192091.USD","BK4139","LU0106831901.USD","LU0306807586.USD","LU1894683348.USD","BAC","LU0128525689.USD","LU0477156797.USD","LU0321505868.SGD","IE00BLSP4239.USD","CAN","LU1791807156.HKD","BK4600"],"gpt_icon":0},{"id":"2540708300","title":"Candel Therapeutics to hold a conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708300","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708300?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:35","pubTimestamp":1748961311,"startTime":"0","endTime":"0","summary":"Management discusses expert clinical perspectives on CAN-2409 Phase 3 prostate cancer data on a conference call to be held on June 3 at 1 pm. Webca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-to-hold-a-conference-call-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-to-hold-a-conference-call-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4600","BK4139","BK4007","BK4526","LENZ","BK4170","BK4539","BK4595","CADL"],"gpt_icon":0},{"id":"2540719368","title":"Candel Therapeutics Inc. Releases Presentation Highlighting Advances in Cancer Immunotherapy and Promising Clinical Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2540719368","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540719368?lang=en_us&edition=fundamental","pubTime":"2025-06-03 06:52","pubTimestamp":1748904754,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc. Releases Presentation Highlighting Advances in Cancer Immunotherapy and Promising Clinical Trial Results. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL4kb7GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4539","BK4139"],"gpt_icon":0},{"id":"2538475311","title":"Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 in Prostate Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2538475311","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538475311?lang=en_us&edition=fundamental","pubTime":"2025-05-28 20:05","pubTimestamp":1748433917,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 in Prostate Cancer Treatment. Candel Therapeutics Inc., a clinical-stage biopharmaceutical company, has announced that the U.S. Food and Drug Administration  has granted Regenerative Medicine Advanced Therapy  designation to its lead candidate, CAN-2409 , for the treatment of newly diagnosed localized prostate cancer in patients with intermediate-to-high-risk disease. This designation is intended to expedite the development and review process for regenerative medicine therapies addressing serious or life-threatening conditions. The RMAT designation was granted based on positive data from Candel's phase 3 clinical trial of CAN-2409 in combination with valacyclovir and standard of care radiation therapy. Candel aims to submit a Biologics License Application by the end of 2026, with the designation helping to facilitate the application process.Disclaimer: This news brief was created by Public ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL9lWK5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","CADL","IE00B64PRP62.GBP","BK4588","BK4539","BK4139","NDAQ","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD"],"gpt_icon":0},{"id":"2538247586","title":"Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for Can-2409 for the Treatment of Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2538247586","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538247586?lang=en_us&edition=fundamental","pubTime":"2025-05-28 20:05","pubTimestamp":1748433900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nTUA2FSXZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4539","BK4139"],"gpt_icon":0},{"id":"2537481920","title":"Candel Therapeutics Unveils Promising Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2537481920","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537481920?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:30","pubTimestamp":1747949447,"startTime":"0","endTime":"0","summary":"An update from Candel Therapeutics ( ($CADL) ) is now available. On May 22, 2025, Candel Therapeutics announced that their phase 3 clinical trial r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-unveils-promising-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-unveils-promising-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","CADL","BK4139"],"gpt_icon":0},{"id":"2537992773","title":"Candel Therapeutics Presents Positive Phase 3 Can-2409 Results in Localized Prostate Cancer at Asco 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537992773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537992773?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:05","pubTimestamp":1747947900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nTUA8ZLWLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CADL","BK4139","BK4539"],"gpt_icon":0},{"id":"2537927753","title":"Candel Therapeutics Inc - Common Can-2409 Adverse Events Include Flu-Like Symptoms, Fever, and Chills","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927753?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:05","pubTimestamp":1747947900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nTUA8ZLWLH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CADL"],"gpt_icon":0},{"id":"2537927738","title":"Candel Therapeutics Inc - Phase 3 Trial Shows 30% Reduction in Prostate Cancer Recurrence Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927738?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:05","pubTimestamp":1747947900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nTUA8ZLWLH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CADL"],"gpt_icon":0},{"id":"2537277879","title":"Candel Therapeutics Inc - Can-2409 Well Tolerated With Low Incidence of Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2537277879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537277879?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:05","pubTimestamp":1747947900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nTUA8ZLWLH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CADL","BK4139"],"gpt_icon":0},{"id":"2535727477","title":"BRIEF-Candel Therapeutics Q1 Net Income USD 7.379 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727477","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727477?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:05","pubTimestamp":1747137945,"startTime":"0","endTime":"0","summary":"BRIEF-Candel Therapeutics Q1 Net Income USD 7.379 Million\n\n\nMay 13 (Reuters) - Candel Therapeutics Q1 operating expenses USD 8.13 million.\n\nQ1 basic EPS USD 0.15\nQ1 income from operations USD -8.13 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLX46D4D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2535272817","title":"Candel Therapeutics Reports Q1 2025 Financials, Highlights Prolonged Survival in Key Trials; No Significant Sales/Revenue Variation Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2535272817","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535272817?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:05","pubTimestamp":1747137920,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Reports Q1 2025 Financials, Highlights Prolonged Survival in Key Trials; No Significant Sales/Revenue Variation Reported. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on May 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDLbDSWlj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","CADL"],"gpt_icon":0},{"id":"2535727441","title":"Candel Therapeutics Inc: Submission of Bla for Can-2409 in Prostate Cancer Expected in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727441?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:05","pubTimestamp":1747137900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLX46D4D5:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CADL","BK4139"],"gpt_icon":0},{"id":"2535272716","title":"Candel Therapeutics Q1 Operating Expenses USD 8.13 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535272716","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535272716?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:05","pubTimestamp":1747137900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLX46D4D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CADL"],"gpt_icon":0},{"id":"2535272677","title":"Press Release: Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2535272677","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535272677?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:05","pubTimestamp":1747137900,"startTime":"0","endTime":"0","summary":"-- Announced accepted oral presentation of positive phase 3 randomized. placebo controlled clinical trial results of CAN-2409 (aglatimagene. besadenovec) in localized prostate cancer at the 2025 American Society of. -- Preparations on track for Biologics License Application  for. -- Recently announced both prolonged median overall survival  and a. long tail of survival in an open label phase 2a clinical trial of. \"During the quarter, we continued our strong momentum of compelling clinical evidence, reinforcing our promising pipeline of pan solid tumor immunotherapies,\" said Paul Peter Tak, MD PhD FMedSci, President and CEO of Candel. \"Our primary focus for 2025 remains on working toward CAN-2409's BLA submission for prostate cancer, which we believe represents a very significant unmet medical need and opportunity for value creation. In this indication, we observed the ability of CAN-2409 to reduce the risk of prostate cancer recurrence compared to standard of care, through meeting the ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4600","BK4139","BK4007","BK4526","CADL","BK4539","LENZ","IDEA","BK4595","BK4135","BK4170"],"gpt_icon":1},{"id":"2533055889","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2533055889","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533055889?lang=en_us&edition=fundamental","pubTime":"2025-05-08 18:00","pubTimestamp":1746698400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLAR","TCPC","CADL","SKIN","BN","BBD","DCTH","CROX","CHH","CLFD","AGO","CVRX","CBLL","ALIT","CIM","AKAM","DDS","ABCL","ALXO","BIOX","AMLX","AUR","CCEC","ATHM","BCE","CARS","LNG","ATXS","AVTX","BILL","CRNX","AVPT","BIGC","CDTX","LNT","RCEL","ARLO","ABEV","CTXR","BBDC","ADVM","ABEO","AXGN","CMPS","CNQ","COP","IPSC","CION","BW"],"gpt_icon":1},{"id":"2529665225","title":"Candel Therapeutics’ CAN-2409 Trial Results Accepted at ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2529665225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529665225?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:55","pubTimestamp":1745441753,"startTime":"0","endTime":"0","summary":"An announcement from Candel Therapeutics ( ($CADL) ) is now available. On April 23, 2025, Candel Therapeutics announced that an abstract featuring ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-can-2409-trial-results-accepted-at-asco?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-can-2409-trial-results-accepted-at-asco?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4600","BK4007","CADL","BK4526","BK4170","BK4595","BK4139","LENZ"],"gpt_icon":0},{"id":"2529650346","title":"Candel Therapeutics Announces Oral Presentation of Positive Phase 3 Can-2409 Results in Localized Prostate Cancer at Asco 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529650346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529650346?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:05","pubTimestamp":1745438701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nTUA8KQ0LL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CADL"],"gpt_icon":0},{"id":"2529696496","title":"Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529696496","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529696496?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:05","pubTimestamp":1745438700,"startTime":"0","endTime":"0","summary":"NEEDHAM, Mass., April 23, 2025  -- Candel Therapeutics, Inc.  , a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that an abstract was accepted for an oral presentation at the 2025 American Society of Clinical Oncology  Annual Meeting taking place May 30 to June 3, 2025, in Chicago, IL. The oral presentation will feature data from the Company’s phase 3 clinical trial of CAN-2409 in patients with intermediate-to-high risk localized prostate cancer.Abstract Title: Phase 3, randomized, placebo-controlled clinical trial of CAN-2409+prodrug in combination with standard-of-care external beam radiation therapy  for newly diagnosed localized prostate cancer. Presenter: Theodore DeWeese, M.D. *, the Francis Watt Baker, M.D., and Lenox D. Baker Jr., M.D., Dean of the Medical Faculty and CEO, Johns Hopkins Medicine. Session Title: Oral Abstract Session – Genitourinary Cancer – Prostate, Testicular,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/candel-therapeutics-announces-oral-presentation-200500766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4526","BK4139","BK4585","LU0053666078.USD","CADL","BK4600","LENZ","BK4170","BK4588","BK4107","BK4595","L"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":101,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CADL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"CADL","fiscalQuarterEnding":"2025/03","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":0.13},{"market":"US","date":"2021-09-08","symbol":"CADL","fiscalQuarterEnding":"2021/06","expectedEps":-0.36,"name":null,"time":"","type":"earning","dateTimestamp":1631073600000,"reportTimeType":"","actualEps":-0.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CADL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CADL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1740110400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CADL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CADL","date":"2025-06-06","current":-7.026047,"percent":0.127992,"low":-19.090472,"twenty":-5.981068,"median":-3.98897,"eighty":-1.634621,"high":-0.606705,"avg":-4.180414,"sd":2.55321,"marketCap":278069868},"quantilePoints":[{"date":"2021-07-23","current":-17.029133,"twenty":-17.029085,"median":-17.029014,"eighty":-11.621563,"marketCap":347155900},{"date":"2021-07-30","current":-10.349763,"twenty":-17.029085,"median":-10.15204,"eighty":-9.455238,"marketCap":210990265},{"date":"2021-08-06","current":-10.267947,"twenty":-14.357314,"median":-10.227038,"eighty":-9.708868,"marketCap":209322358},{"date":"2021-08-13","current":-10.349763,"twenty":-11.418829,"median":-10.322491,"eighty":-10.063405,"marketCap":210990265},{"date":"2021-08-20","current":-8.865134,"twenty":-11.028838,"median":-10.227038,"eighty":-9.408343,"marketCap":180724622},{"date":"2021-08-27","current":-11.257313,"twenty":-11.217913,"median":-10.322491,"eighty":-9.474894,"marketCap":229491584},{"date":"2021-09-03","current":-11.468388,"twenty":-11.293511,"median":-10.349763,"eighty":-9.703414,"marketCap":233794551},{"date":"2021-09-10","current":-9.040742,"twenty":-11.303556,"median":-10.349763,"eighty":-9.401791,"marketCap":312719277},{"date":"2021-09-17","current":-6.502699,"twenty":-11.262165,"median":-10.281583,"eighty":-9.046428,"marketCap":224928361},{"date":"2021-09-24","current":-8.236199,"twenty":-11.24887,"median":-10.227038,"eighty":-8.247811,"marketCap":284890131},{"date":"2021-10-01","current":-8.708972,"twenty":-11.206655,"median":-9.947499,"eighty":-8.297577,"marketCap":301243341},{"date":"2021-10-08","current":-8.908034,"twenty":-11.170069,"median":-9.428,"eighty":-8.297577,"marketCap":308128903},{"date":"2021-10-15","current":-8.153257,"twenty":-11.133483,"median":-9.293717,"eighty":-8.209657,"marketCap":282021146},{"date":"2021-10-22","current":-7.987371,"twenty":-11.023724,"median":-9.069173,"eighty":-8.121739,"marketCap":276283178},{"date":"2021-10-29","current":-9.314453,"twenty":-10.93648,"median":-9.202481,"eighty":-8.133351,"marketCap":322186925},{"date":"2021-11-05","current":-8.974388,"twenty":-10.713478,"median":-9.297864,"eighty":-8.159892,"marketCap":310424090},{"date":"2021-11-12","current":-6.56858,"twenty":-10.611575,"median":-9.277128,"eighty":-8.159892,"marketCap":316592406},{"date":"2021-11-19","current":-6.470364,"twenty":-10.349763,"median":-9.115391,"eighty":-8.061219,"marketCap":311858582},{"date":"2021-11-26","current":-5.821541,"twenty":-10.349763,"median":-9.069173,"eighty":-7.987371,"marketCap":280586654},{"date":"2021-12-03","current":-5.595347,"twenty":-10.349763,"median":-8.982682,"eighty":-6.900824,"marketCap":269684514},{"date":"2021-12-10","current":-5.250102,"twenty":-10.295219,"median":-8.865134,"eighty":-6.502699,"marketCap":253044406},{"date":"2021-12-17","current":-3.773883,"twenty":-10.267947,"median":-8.688236,"eighty":-6.309646,"marketCap":181893598},{"date":"2021-12-23","current":-5.000097,"twenty":-10.23522,"median":-8.576264,"eighty":-5.981068,"marketCap":240994672},{"date":"2021-12-31","current":-4.654852,"twenty":-10.227038,"median":-8.518204,"eighty":-5.90437,"marketCap":224354564},{"date":"2022-01-07","current":-4.017935,"twenty":-10.227038,"median":-8.385496,"eighty":-5.676301,"marketCap":193656433},{"date":"2022-01-14","current":-3.72031,"twenty":-10.008861,"median":-8.236199,"eighty":-5.200101,"marketCap":179311512},{"date":"2022-01-21","current":-3.60126,"twenty":-9.946135,"median":-8.186434,"eighty":-4.754854,"marketCap":173573544},{"date":"2022-01-28","current":-2.672671,"twenty":-9.898373,"median":-8.124227,"eighty":-4.622709,"marketCap":128817390},{"date":"2022-02-04","current":-2.476238,"twenty":-9.775613,"median":-8.053725,"eighty":-4.401276,"marketCap":119349742},{"date":"2022-02-11","current":-2.375046,"twenty":-9.707601,"median":-7.999813,"eighty":-4.161985,"marketCap":114472469},{"date":"2022-02-18","current":-2.506001,"twenty":-9.629635,"median":-6.99206,"eighty":-4.070317,"marketCap":120784234},{"date":"2022-02-25","current":-2.648861,"twenty":-9.566016,"median":-6.900824,"eighty":-3.991744,"marketCap":127669796},{"date":"2022-03-04","current":-2.464333,"twenty":-9.542501,"median":-6.701524,"eighty":-3.776264,"marketCap":118775945},{"date":"2022-03-11","current":-2.291711,"twenty":-9.53508,"median":-6.470364,"eighty":-3.64888,"marketCap":110455891},{"date":"2022-03-18","current":-2.809578,"twenty":-9.489262,"median":-6.339408,"eighty":-2.81434,"marketCap":135416054},{"date":"2022-03-25","current":-2.708386,"twenty":-9.414896,"median":-6.142976,"eighty":-2.740529,"marketCap":130538781},{"date":"2022-04-01","current":-4.169755,"twenty":-9.36956,"median":-5.967377,"eighty":-2.740529,"marketCap":150628212},{"date":"2022-04-08","current":-3.883828,"twenty":-9.324406,"median":-5.922101,"eighty":-2.763149,"marketCap":140299420},{"date":"2022-04-14","current":-4.1221,"twenty":-9.314453,"median":-5.821541,"eighty":-2.795292,"marketCap":148906746},{"date":"2022-04-22","current":-3.875886,"twenty":-9.311135,"median":-5.645943,"eighty":-2.811959,"marketCap":140012509},{"date":"2022-04-29","current":-2.843375,"twenty":-9.296205,"median":-5.369152,"eighty":-2.822674,"marketCap":102714095},{"date":"2022-05-06","current":-2.954569,"twenty":-9.284593,"median":-4.991168,"eighty":-2.829035,"marketCap":106730847},{"date":"2022-05-13","current":-3.529293,"twenty":-9.234828,"median":-4.74414,"eighty":-2.829035,"marketCap":114772604},{"date":"2022-05-20","current":-3.096954,"twenty":-9.115391,"median":-4.651876,"eighty":-2.837021,"marketCap":100712960},{"date":"2022-05-27","current":-3.749874,"twenty":-9.108756,"median":-4.535802,"eighty":-2.837021,"marketCap":121945891},{"date":"2022-06-03","current":-3.326359,"twenty":-9.082214,"median":-4.43461,"eighty":-2.843375,"marketCap":108173179},{"date":"2022-06-10","current":-2.938136,"twenty":-9.069173,"median":-4.363766,"eighty":-2.863151,"marketCap":95548192},{"date":"2022-06-17","current":-3.061662,"twenty":-9.040742,"median":-4.226272,"eighty":-2.898972,"marketCap":99565233},{"date":"2022-06-24","current":-3.088131,"twenty":-9.00093,"median":-4.166747,"eighty":-2.91168,"marketCap":100426028},{"date":"2022-07-01","current":-2.832258,"twenty":-8.977706,"median":-4.148404,"eighty":-2.891808,"marketCap":92105014},{"date":"2022-07-08","current":-3.088131,"twenty":-8.934576,"median":-4.117637,"eighty":-2.884644,"marketCap":100426028},{"date":"2022-07-15","current":-2.94696,"twenty":-8.882294,"median":-4.074446,"eighty":-2.861381,"marketCap":95835124},{"date":"2022-07-22","current":-2.823434,"twenty":-8.771437,"median":-4.04221,"eighty":-2.861381,"marketCap":91818083},{"date":"2022-07-29","current":-2.735202,"twenty":-8.708972,"median":-4.00603,"eighty":-2.861381,"marketCap":88948768},{"date":"2022-08-05","current":-5.162167,"twenty":-8.684089,"median":-3.988621,"eighty":-2.861381,"marketCap":101121681},{"date":"2022-08-12","current":-4.963054,"twenty":-8.617735,"median":-4.017935,"eighty":-2.871085,"marketCap":97221273},{"date":"2022-08-19","current":-5.10317,"twenty":-8.574605,"median":-4.05459,"eighty":-2.876374,"marketCap":99966005},{"date":"2022-08-26","current":-4.970429,"twenty":-8.548064,"median":-4.089365,"eighty":-2.889933,"marketCap":97365733},{"date":"2022-09-02","current":-4.822938,"twenty":-8.52484,"median":-4.132518,"eighty":-2.906589,"marketCap":94476542},{"date":"2022-09-09","current":-6.017611,"twenty":-8.511568,"median":-4.154356,"eighty":-2.912943,"marketCap":117878988},{"date":"2022-09-16","current":-4.79344,"twenty":-8.485027,"median":-4.169755,"eighty":-2.920639,"marketCap":93898704},{"date":"2022-09-23","current":-4.911433,"twenty":-8.400426,"median":-4.300679,"eighty":-2.929313,"marketCap":96210056},{"date":"2022-09-30","current":-4.631201,"twenty":-8.304212,"median":-4.415969,"eighty":-2.932842,"marketCap":90720594},{"date":"2022-10-07","current":-4.424714,"twenty":-8.271035,"median":-4.449491,"eighty":-2.941666,"marketCap":86675727},{"date":"2022-10-14","current":-3.746258,"twenty":-8.222928,"median":-4.424714,"eighty":-2.950004,"marketCap":73385448},{"date":"2022-10-21","current":-2.654829,"twenty":-8.196387,"median":-4.363766,"eighty":-2.941666,"marketCap":52005436},{"date":"2022-10-28","current":-2.861315,"twenty":-8.173163,"median":-4.250082,"eighty":-2.920639,"marketCap":56050303},{"date":"2022-11-04","current":-2.286102,"twenty":-8.143304,"median":-4.179242,"eighty":-2.876374,"marketCap":44782458},{"date":"2022-11-11","current":-3.866531,"twenty":-8.125056,"median":-4.154842,"eighty":-2.868316,"marketCap":46843024},{"date":"2022-11-18","current":-4.221416,"twenty":-8.108526,"median":-4.168251,"eighty":-2.876188,"marketCap":51142457},{"date":"2022-11-25","current":-4.364515,"twenty":-8.0837,"median":-4.160794,"eighty":-2.876374,"marketCap":52876100},{"date":"2022-12-02","current":-4.483764,"twenty":-8.046299,"median":-4.166747,"eighty":-2.880894,"marketCap":54320802},{"date":"2022-12-09","current":-4.98461,"twenty":-8.015727,"median":-4.168251,"eighty":-2.901511,"marketCap":60388551},{"date":"2022-12-16","current":-3.935218,"twenty":-8.007277,"median":-4.173717,"eighty":-2.912305,"marketCap":47675172},{"date":"2022-12-23","current":-3.625171,"twenty":-7.985712,"median":-4.160794,"eighty":-2.917748,"marketCap":43918946},{"date":"2022-12-30","current":-4.269116,"twenty":-7.979077,"median":-4.154356,"eighty":-2.929313,"marketCap":51720338},{"date":"2023-01-06","current":-4.722262,"twenty":-7.189463,"median":-4.168251,"eighty":-2.929313,"marketCap":57210207},{"date":"2023-01-13","current":-4.96076,"twenty":-6.925706,"median":-4.173717,"eighty":-2.936371,"marketCap":60099611},{"date":"2023-01-20","current":-5.676255,"twenty":-6.904142,"median":-4.197566,"eighty":-2.94343,"marketCap":68767824},{"date":"2023-01-27","current":-6.367899,"twenty":-6.895847,"median":-4.223844,"eighty":-2.948669,"marketCap":77147097},{"date":"2023-02-03","current":-5.771654,"twenty":-6.857693,"median":-4.269116,"eighty":-2.949809,"marketCap":69923586},{"date":"2023-02-10","current":-4.89088,"twenty":-6.674936,"median":-4.30489,"eighty":-2.952665,"marketCap":59253016},{"date":"2023-02-17","current":-5.00846,"twenty":-6.529051,"median":-4.364515,"eighty":-2.960591,"marketCap":60677492},{"date":"2023-02-24","current":-4.674563,"twenty":-6.496479,"median":-4.388365,"eighty":-2.964606,"marketCap":56632326},{"date":"2023-03-03","current":-4.102167,"twenty":-6.480434,"median":-4.382311,"eighty":-2.964606,"marketCap":49697755},{"date":"2023-03-10","current":-3.863669,"twenty":-6.429887,"median":-4.376257,"eighty":-2.968135,"marketCap":46808351},{"date":"2023-03-17","current":-3.410523,"twenty":-6.369171,"median":-4.334045,"eighty":-2.975416,"marketCap":41318482},{"date":"2023-03-24","current":-3.553622,"twenty":-6.368662,"median":-4.292966,"eighty":-2.983468,"marketCap":43052125},{"date":"2023-03-31","current":-2.077351,"twenty":-6.367899,"median":-4.27317,"eighty":-2.975416,"marketCap":39041743},{"date":"2023-04-06","current":-2.185066,"twenty":-6.356248,"median":-4.247674,"eighty":-2.964606,"marketCap":41066130},{"date":"2023-04-14","current":-2.092739,"twenty":-6.281074,"median":-4.221416,"eighty":-2.94753,"marketCap":39330941},{"date":"2023-04-21","current":-2.169678,"twenty":-6.162024,"median":-4.193148,"eighty":-2.917748,"marketCap":40776932},{"date":"2023-04-28","current":-2.056424,"twenty":-6.140023,"median":-4.173717,"eighty":-2.876374,"marketCap":38648434},{"date":"2023-05-05","current":-2.615924,"twenty":-6.106089,"median":-4.160794,"eighty":-2.861315,"marketCap":49163677},{"date":"2023-05-12","current":-2.6467,"twenty":-6.010541,"median":-4.149867,"eighty":-2.837021,"marketCap":49742073},{"date":"2023-05-19","current":-1.85037,"twenty":-5.981068,"median":-4.134477,"eighty":-2.824234,"marketCap":49432631},{"date":"2023-05-26","current":-1.580495,"twenty":-5.973535,"median":-4.113175,"eighty":-2.802319,"marketCap":42222922},{"date":"2023-06-02","current":-1.634621,"twenty":-5.962452,"median":-4.102167,"eighty":-2.791721,"marketCap":43668913},{"date":"2023-06-09","current":-1.721224,"twenty":-5.958449,"median":-4.083841,"eighty":-2.738148,"marketCap":45982497},{"date":"2023-06-16","current":-1.548019,"twenty":-5.940591,"median":-4.074446,"eighty":-2.708386,"marketCap":41355328},{"date":"2023-06-23","current":-1.299037,"twenty":-5.925799,"median":-4.054468,"eighty":-2.678393,"marketCap":34703772},{"date":"2023-06-30","current":-1.342338,"twenty":-5.868908,"median":-4.041745,"eighty":-2.666718,"marketCap":35860564},{"date":"2023-07-07","current":-1.331513,"twenty":-5.828684,"median":-4.017935,"eighty":-2.648861,"marketCap":35571366},{"date":"2023-07-14","current":-1.299037,"twenty":-5.817375,"median":-4.000526,"eighty":-2.625586,"marketCap":34703772},{"date":"2023-07-21","current":-1.384124,"twenty":-5.795337,"median":-3.98222,"eighty":-2.553621,"marketCap":36976869},{"date":"2023-07-28","current":-1.169133,"twenty":-5.762114,"median":-3.959068,"eighty":-2.526239,"marketCap":31233394},{"date":"2023-08-04","current":-1.147483,"twenty":-5.747804,"median":-3.935218,"eighty":-2.502429,"marketCap":30654998},{"date":"2023-08-11","current":-0.95261,"twenty":-5.736822,"median":-3.883828,"eighty":-2.469095,"marketCap":30654998},{"date":"2023-08-18","current":-1.015518,"twenty":-5.710825,"median":-3.867944,"eighty":-2.435835,"marketCap":32679385},{"date":"2023-08-25","current":-1.159309,"twenty":-5.688425,"median":-3.851744,"eighty":-2.416215,"marketCap":37306554},{"date":"2023-09-01","current":-1.0964,"twenty":-5.652405,"median":-3.83936,"eighty":-2.375046,"marketCap":35282168},{"date":"2023-09-08","current":-1.055959,"twenty":-5.61663,"median":-3.82029,"eighty":-2.3156,"marketCap":33980776},{"date":"2023-09-15","current":-1.087414,"twenty":-5.599604,"median":-3.776859,"eighty":-2.275044,"marketCap":34992970},{"date":"2023-09-22","current":-1.024505,"twenty":-5.583753,"median":-3.749874,"eighty":-2.184625,"marketCap":32968583},{"date":"2023-09-27","current":-0.898689,"twenty":-5.570863,"median":-3.746258,"eighty":-2.179463,"marketCap":28919810},{"date":"2023-10-06","current":-0.772872,"twenty":-5.526576,"median":-3.732215,"eighty":-2.15429,"marketCap":24871036},{"date":"2023-10-13","current":-0.80882,"twenty":-5.509306,"median":-3.672871,"eighty":-2.12967,"marketCap":26027829},{"date":"2023-10-20","current":-0.80891,"twenty":-5.504536,"median":-3.635364,"eighty":-2.092739,"marketCap":26030720},{"date":"2023-10-27","current":-0.772962,"twenty":-5.499766,"median":-3.625171,"eighty":-2.083506,"marketCap":24873928},{"date":"2023-11-03","current":-0.772872,"twenty":-5.475291,"median":-3.577471,"eighty":-2.065041,"marketCap":24871036},{"date":"2023-11-10","current":-0.788055,"twenty":-5.430485,"median":-3.553622,"eighty":-1.861913,"marketCap":25160234},{"date":"2023-11-17","current":-0.932985,"twenty":-5.404956,"median":-3.529772,"eighty":-1.801331,"marketCap":29787404},{"date":"2023-11-24","current":-0.887241,"twenty":-5.369152,"median":-3.529293,"eighty":-1.721224,"marketCap":28326953},{"date":"2023-12-01","current":-0.814324,"twenty":-5.366446,"median":-3.508229,"eighty":-1.688748,"marketCap":25998909},{"date":"2023-12-08","current":-0.815229,"twenty":-5.366207,"median":-3.432237,"eighty":-1.656272,"marketCap":26027829},{"date":"2023-12-15","current":-1.19567,"twenty":-5.309657,"median":-3.401356,"eighty":-1.59132,"marketCap":38174149},{"date":"2023-12-22","current":-1.014508,"twenty":-5.294908,"median":-3.364254,"eighty":-1.548019,"marketCap":32390187},{"date":"2023-12-29","current":-1.259076,"twenty":-5.280448,"median":-3.357826,"eighty":-1.472242,"marketCap":40198535},{"date":"2024-01-05","current":-1.349658,"twenty":-5.266667,"median":-3.338973,"eighty":-1.384427,"marketCap":43090516},{"date":"2024-01-12","current":-1.159437,"twenty":-5.249473,"median":-3.33077,"eighty":-1.350359,"marketCap":37017356},{"date":"2024-01-19","current":-1.168495,"twenty":-5.246958,"median":-3.320741,"eighty":-1.342338,"marketCap":37306554},{"date":"2024-01-26","current":-1.141321,"twenty":-5.176916,"median":-3.299889,"eighty":-1.331513,"marketCap":36438960},{"date":"2024-02-02","current":-1.19567,"twenty":-5.162167,"median":-3.216068,"eighty":-1.299037,"marketCap":38174149},{"date":"2024-02-09","current":-1.14585,"twenty":-5.162167,"median":-3.132247,"eighty":-1.277386,"marketCap":36583559},{"date":"2024-02-16","current":-1.57611,"twenty":-5.162167,"median":-3.097243,"eighty":-1.277386,"marketCap":50320469},{"date":"2024-02-23","current":-1.569679,"twenty":-5.162167,"median":-3.092543,"eighty":-1.291724,"marketCap":50115138},{"date":"2024-03-01","current":-1.684807,"twenty":-5.162167,"median":-3.088131,"eighty":-1.298291,"marketCap":53790846},{"date":"2024-03-08","current":-1.38589,"twenty":-5.162167,"median":-3.070485,"eighty":-1.299037,"marketCap":44247309},{"date":"2024-03-15","current":-1.413064,"twenty":-5.150368,"median":-3.052838,"eighty":-1.299037,"marketCap":45114903},{"date":"2024-03-22","current":-1.313425,"twenty":-5.123819,"median":-3.046946,"eighty":-1.299037,"marketCap":41933724},{"date":"2024-03-28","current":-1.173898,"twenty":-5.117919,"median":-3.034152,"eighty":-1.299037,"marketCap":44536507},{"date":"2024-04-05","current":-4.950679,"twenty":-5.109483,"median":-3.026369,"eighty":-1.299037,"marketCap":187823795},{"date":"2024-04-12","current":-5.631397,"twenty":-5.117919,"median":-3.042975,"eighty":-1.299037,"marketCap":213649567},{"date":"2024-04-19","current":-4.223548,"twenty":-5.117919,"median":-3.052838,"eighty":-1.299037,"marketCap":160237175},{"date":"2024-04-26","current":-4.973885,"twenty":-5.109483,"median":-3.061662,"eighty":-1.299347,"marketCap":188704219},{"date":"2024-05-03","current":-6.520972,"twenty":-5.125283,"median":-3.079308,"eighty":-1.304195,"marketCap":247399155},{"date":"2024-05-10","current":-7.712229,"twenty":-5.162167,"median":-3.088131,"eighty":-1.310971,"marketCap":292594255},{"date":"2024-05-17","current":-9.974919,"twenty":-5.162167,"median":-3.096954,"eighty":-1.313425,"marketCap":372712843},{"date":"2024-05-24","current":-8.396211,"twenty":-5.258384,"median":-3.119013,"eighty":-1.317783,"marketCap":313724432},{"date":"2024-05-31","current":-7.087607,"twenty":-5.343587,"median":-3.182392,"eighty":-1.325018,"marketCap":264828444},{"date":"2024-06-07","current":-5.693977,"twenty":-5.42634,"median":-3.264596,"eighty":-1.335843,"marketCap":212755435},{"date":"2024-06-14","current":-5.805467,"twenty":-5.509306,"median":-3.311917,"eighty":-1.342338,"marketCap":216921276},{"date":"2024-06-21","current":-4.810017,"twenty":-5.509306,"median":-3.326359,"eighty":-1.342338,"marketCap":179726270},{"date":"2024-06-28","current":-4.937434,"twenty":-5.504536,"median":-3.338973,"eighty":-1.342338,"marketCap":184487231},{"date":"2024-07-05","current":-4.634817,"twenty":-5.485456,"median":-3.352828,"eighty":-1.342338,"marketCap":173179949},{"date":"2024-07-12","current":-4.857798,"twenty":-5.453482,"median":-3.372636,"eighty":-1.342338,"marketCap":181511630},{"date":"2024-07-19","current":-4.786126,"twenty":-5.453482,"median":-3.405768,"eighty":-1.349658,"marketCap":178833590},{"date":"2024-07-26","current":-5.335614,"twenty":-5.434629,"median":-3.456506,"eighty":-1.349658,"marketCap":199365233},{"date":"2024-08-02","current":-4.30831,"twenty":-5.413907,"median":-3.510536,"eighty":-1.349658,"marketCap":160979987},{"date":"2024-08-09","current":-4.547218,"twenty":-5.369152,"median":-3.529293,"eighty":-1.353163,"marketCap":169906788},{"date":"2024-08-16","current":-3.382547,"twenty":-5.366446,"median":-3.529293,"eighty":-1.353163,"marketCap":169086774},{"date":"2024-08-23","current":-3.645706,"twenty":-5.366207,"median":-3.519915,"eighty":-1.353163,"marketCap":182241533},{"date":"2024-08-30","current":-4.332485,"twenty":-5.351542,"median":-3.529293,"eighty":-1.353701,"marketCap":216572244},{"date":"2024-09-06","current":-3.940956,"twenty":-5.3388,"median":-3.529772,"eighty":-1.357713,"marketCap":197000530},{"date":"2024-09-13","current":-4.499366,"twenty":-5.314848,"median":-3.563848,"eighty":-1.358716,"marketCap":224914286},{"date":"2024-09-20","current":-4.839546,"twenty":-5.297858,"median":-3.60126,"eighty":-1.358716,"marketCap":241919218},{"date":"2024-09-27","current":-4.627735,"twenty":-5.276506,"median":-3.645632,"eighty":-1.358716,"marketCap":231331242},{"date":"2024-10-04","current":-4.2683,"twenty":-5.271028,"median":-3.672871,"eighty":-1.373209,"marketCap":213363767},{"date":"2024-10-11","current":-3.863934,"twenty":-5.254243,"median":-3.732215,"eighty":-1.382666,"marketCap":193150357},{"date":"2024-10-18","current":-3.889608,"twenty":-5.247587,"median":-3.746258,"eighty":-1.385336,"marketCap":194433748},{"date":"2024-10-25","current":-3.594358,"twenty":-5.235062,"median":-3.74427,"eighty":-1.38584,"marketCap":179674751},{"date":"2024-11-01","current":-3.388966,"twenty":-5.219346,"median":-3.687262,"eighty":-1.40301,"marketCap":169407622},{"date":"2024-11-08","current":-3.100133,"twenty":-5.190677,"median":-3.652177,"eighty":-1.411909,"marketCap":154969472},{"date":"2024-11-15","current":-2.364165,"twenty":-5.178394,"median":-3.645706,"eighty":-1.42031,"marketCap":123407040},{"date":"2024-11-22","current":-3.135629,"twenty":-5.165117,"median":-3.613215,"eighty":-1.422122,"marketCap":163676706},{"date":"2024-11-29","current":-2.927209,"twenty":-5.162167,"median":-3.585915,"eighty":-1.427557,"marketCap":152797401},{"date":"2024-12-06","current":-3.197844,"twenty":-5.162167,"median":-3.553622,"eighty":-1.447485,"marketCap":166924260},{"date":"2024-12-13","current":-5.492632,"twenty":-5.162167,"median":-3.563848,"eighty":-1.469225,"marketCap":286709881},{"date":"2024-12-20","current":-7.120078,"twenty":-5.197048,"median":-3.594358,"eighty":-1.487341,"marketCap":371660957},{"date":"2024-12-27","current":-7.217725,"twenty":-5.248844,"median":-3.625171,"eighty":-1.502969,"marketCap":376758022},{"date":"2025-01-03","current":-7.502528,"twenty":-5.290308,"median":-3.645706,"eighty":-1.516787,"marketCap":391624460},{"date":"2025-01-10","current":-6.656256,"twenty":-5.335614,"median":-3.649021,"eighty":-1.521762,"marketCap":347449900},{"date":"2025-01-17","current":-5.423465,"twenty":-5.369152,"median":-3.680067,"eighty":-1.526368,"marketCap":283099460},{"date":"2025-01-24","current":-5.606553,"twenty":-5.415819,"median":-3.732215,"eighty":-1.52993,"marketCap":292656456},{"date":"2025-01-31","current":-5.753023,"twenty":-5.438092,"median":-3.746258,"eighty":-1.538066,"marketCap":300302053},{"date":"2025-02-07","current":-7.046843,"twenty":-5.495967,"median":-3.749138,"eighty":-1.546391,"marketCap":367838159},{"date":"2025-02-14","current":-7.364195,"twenty":-5.568865,"median":-3.761239,"eighty":-1.555999,"marketCap":384403618},{"date":"2025-02-21","current":-9.463601,"twenty":-5.601669,"median":-3.773883,"eighty":-1.557994,"marketCap":493990506},{"date":"2025-02-28","current":-7.303166,"twenty":-5.666143,"median":-3.79212,"eighty":-1.565,"marketCap":381217953},{"date":"2025-03-07","current":-6.721354,"twenty":-5.706063,"median":-3.836174,"eighty":-1.56967,"marketCap":350847943},{"date":"2025-03-14","current":-7.490626,"twenty":-5.748571,"median":-3.839819,"eighty":-1.569675,"marketCap":413310275},{"date":"2025-03-21","current":-6.899937,"twenty":-5.805467,"median":-3.851098,"eighty":-1.573538,"marketCap":380717807},{"date":"2025-03-28","current":-5.089345,"twenty":-5.819489,"median":-3.863802,"eighty":-1.57611,"marketCap":280814809},{"date":"2025-04-04","current":-4.126265,"twenty":-5.813923,"median":-3.867944,"eighty":-1.578741,"marketCap":227674917},{"date":"2025-04-11","current":-4.254676,"twenty":-5.80773,"median":-3.879857,"eighty":-1.583299,"marketCap":234760236},{"date":"2025-04-17","current":-3.912247,"twenty":-5.805467,"median":-3.883828,"eighty":-1.587629,"marketCap":215866052},{"date":"2025-04-25","current":-4.263236,"twenty":-5.791942,"median":-3.889608,"eighty":-1.592482,"marketCap":235232590},{"date":"2025-05-02","current":-4.714715,"twenty":-5.764202,"median":-3.907346,"eighty":-1.601473,"marketCap":260143847},{"date":"2025-05-09","current":-4.295034,"twenty":-5.751703,"median":-3.935218,"eighty":-1.61593,"marketCap":236987103},{"date":"2025-05-16","current":-6.772856,"twenty":-5.805467,"median":-3.943014,"eighty":-1.62497,"marketCap":268049332},{"date":"2025-05-23","current":-6.861473,"twenty":-5.828684,"median":-3.959068,"eighty":-1.632124,"marketCap":271556520},{"date":"2025-05-30","current":-7.405833,"twenty":-5.947876,"median":-3.976268,"eighty":-1.634621,"marketCap":293100672},{"date":"2025-06-06","current":-7.026047,"twenty":-5.981068,"median":-3.98897,"eighty":-1.634621,"marketCap":278069868}],"updateTime":1749376094325}}}